In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

The following Adult Congenital Heart Disease related sessions and lectures will be held during the ESC Congress 2014 in Barcelona

Congenital Heart Disease and Pediatric Cardiology
Adult Congenital Heart Disease

Saturday August 30, 11.00 – 12.30, Bishkek - Village 4:
The atrial septal defect: do we know everything?
J.L. Stein (Innsbruck, A), M. Chessa (San Donato Milanese, IT)
1. A pediatric or an adult problem?
E. Jokinen (Helsinki, F)
2. Imaging the types of atrial septal defect
J. Marek (London, GB)
3. The elderly patient: why, when, and how to close the defect?
H. Baumgartner (Munster, DE)
4. Pulmonary hypertension: to close or not to close?
M. Schwerzmann (Bern, CH)

Sunday August 31, 11.00 – 12.30, Bishkek - Village 4:
Pulmonary vascular disease and the Fontan circulation; new paradigms
M.A. Gatzoulis (London, GB), P.J. Holm (Lund, SE)
1. Physiology of the failing Fontan: importance of reduced preload
M. Gewillig (Leuven, BE)
2. Tackling the pulmonary circulation
G.P. Diller (Muenster, DE)
3. Impact of pulmonary vasodilators on exercise capacity and morbidity
M. Beghetti (Geneva, CH)
4. Innovative mechanical support devises
G. Brancaccio (Rome, IT)

Sunday August 31, 14.00 – 15.30, Cairo - Village 4:
The impact of interventional procedures in adult congenital heart disease
C. Naber (Essen, DE), A. Pujuan Domensch (Barcelona, ES)
1. ASD closure – state of the art
S.A. Quereshi (London GB)
2. Coarctation: Is stenting for everybody?
A. Elcken (Munich, DE)
3. Which is the best procedure for the pulmonary valve?
M. Carminati (San Donato Milanese, IT)
4. Percutaneous valve-in-valve implantation in adult congenital hear disease
M. Gewillig (Leuven, BE)

Sunday August 31, 16.30 – 17.30, Cairo – Village 4:
Innovative interventions in congenital heart disease
G.D. Webb (Cincinnati, US), H. Baumgartner (Muenster, DE)
1. The future of transcatheter pulmonary valve therapy
A. Eicken (Munchen, DE)
2. Electrophysiological devices in adult congenital heart disease: pacemakers, defibrillators, and beyond …
P. Khairy (Montreal, CA)
3. Cardiovascular magnetic resonance guided interventions
A.M. Taylor (London, GB)
4. Aortic root surgery in Marfan syndrome: valve-sparing, external wraps?
J. Pepper (London, UK)

Monday September 1, 08.30 – 10.00, Cairo - Village 4:
The challenge of pregnancy in GUCH and cardiomyopathy
S. Thorne (Birmingham, GB), A. Linhart (Prague, CZ)
1. Risk stratification in hereditary cardiomyopathy
P.G. Pieper (Groningen, NL)
2. Risk stratification in congenital heart disease
F. Walker (London, GB)
3. What is new in peripartum cardiomyopathy?
D. Hilfiker-Kleiner (Hannover, DE)
4. How to deal with arrhythmia
F. Hidden Lucet (Paris, FR)

Monday September 1, 11.00 – 12.30, Cairo – Village 4:
Pregnancy considerations in women with congenital and acquired heart disease
S. Thorne (Birmingham, GB), M. Kiess (Vancouver, CA)
1. What are the pregnancy risks for women with aortopathies and how can complications be prevented?
J.W. Roos-Hesselink (Rotterdam, NL)
2. How do you optimise pregnancy outcomes in women with pulmonary hypertension?
J. Grewal (Vancouver, CA)
3. How do you risk stratify and medically manage pregnant women with pre-existing ischaemic heart disease?
P.G. Pieper (Groningen, NL)
4. Prosthetic heart valves: what is the best option for women of childbearing age?
S.C. Siu (London, GB)

Monday September 1, 16.30 – 18.00, Athens – Village 4:
Innovative devices for heart failure in adults with congenital heart disease
P.J. Holm (Lund, SE), B.J.M. Mulder (Amsterdam, NL)
1. Magnitude of the problem, determinants of symptoms and outcome
K. Dimopoulos (London, GB)
2. The role of ICD: can subcutaneous devices reduce morbidity?
L. Eckhardt (Munster, DE)
3. Is there a role for cardiac resynchronization?
J. Janousek (Prague, CZ)
4. Interventional devices to improve heart failure
M.Chessa (San Donato, Milan, IT)

Tuesday September 2, 11.00 – 12.30, Athens - Village 4:
Marfan syndrome, novel insights
H. Kaemmerer (Munich, DE), P. Trigo Trindade (Petit-Lancy, CH)
1. Diagnosis and differential diagnosis
Y. von Kodolitsch (Hamburg, DE)
2. Imaging the aorta
O. Phalla (Paris, FR)
3. Losartan: new evidence
B. Mulder (Amsterdam, NL)
4. New surgical approaches
T. Treasure (London, GB)

Tuesday September 2, 11.00 – 12.30, Bishkek - Village 4:
Challenging cases in adult congenital heart disease
H. Baumgartner (Muenster, DE), F.J. Meijboom (Utrecht, NL)
1. Introduction to the session
H. Baumgartner (Muenster, DE)
2. Pulmonary regurgitation after repaired tetralogy of Fallot
A. Elcken (Munich, DE)
3. Panel discussion and questions from the audience
A. Elcken (Munich, DE), J.E. Deanfield (London, GB), M. Schwerzmann (Bern, CH)
4. Dilated aorta
J.W. Roos-Hesselink (Rotterdam, NL)
5. Panel discussion and questions from the audience
J.W. Roos-Hesselink (Rotterdam, NL), J.E. Deanfield (London, GB), M. Schwerzmann (Bern, CH)
6. Syncope after Mustard repair of transposition
W. Budts (Leuven, BE)
7. Panel discussion and questions from the audience
W. Budts (Leuven BE), J.E. Deanfield (London, GB), M. Schwerzmann (Bern, CH)
8. Take home message on the cases presented
F.J. Meijboom (Utrecht, NL)